1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Retinitis Pigmentosa Treatment & Management Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Vitamin A 1.2.3 Docosahexaenoic Acid 1.2.4 Calcium Channel Blockers 1.2.5 Gene Therapy 1.2.6 Retinal Eye Prosthetics 1.3 Market by Application 1.3.1 Global Retinitis Pigmentosa Treatment & Management Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Retinitis Pigmentosa Treatment & Management Market Size (2017-2028) 2.2 Retinitis Pigmentosa Treatment & Management Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Retinitis Pigmentosa Treatment & Management Market Size by Region (2017-2022) 2.4 Global Retinitis Pigmentosa Treatment & Management Market Size Forecast by Region (2023-2028) 2.5 Global Top Retinitis Pigmentosa Treatment & Management Countries Ranking by Market Size 3 Retinitis Pigmentosa Treatment & Management Competitive by Company 3.1 Global Retinitis Pigmentosa Treatment & Management Revenue by Players 3.1.1 Global Retinitis Pigmentosa Treatment & Management Revenue by Players (2017-2022) 3.1.2 Global Retinitis Pigmentosa Treatment & Management Market Share by Players (2017-2022) 3.2 Global Retinitis Pigmentosa Treatment & Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Retinitis Pigmentosa Treatment & Management Revenue 3.4 Global Retinitis Pigmentosa Treatment & Management Market Concentration Ratio 3.4.1 Global Retinitis Pigmentosa Treatment & Management Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa Treatment & Management Revenue in 2021 3.5 Global Retinitis Pigmentosa Treatment & Management Key Players Head office and Area Served 3.6 Key Players Retinitis Pigmentosa Treatment & Management Product Solution and Service 3.7 Date of Enter into Retinitis Pigmentosa Treatment & Management Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Retinitis Pigmentosa Treatment & Management Breakdown Data by Type 4.1 Global Retinitis Pigmentosa Treatment & Management Historic Revenue by Type (2017-2022) 4.2 Global Retinitis Pigmentosa Treatment & Management Forecasted Revenue by Type (2023-2028) 5 Global Retinitis Pigmentosa Treatment & Management Breakdown Data by Application 5.1 Global Retinitis Pigmentosa Treatment & Management Historic Market Size by Application (2017-2022) 5.2 Global Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) 6.2 North America Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2028) 6.3 North America Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2028) 6.4 North America Retinitis Pigmentosa Treatment & Management Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) 7.2 Europe Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2028) 7.3 Europe Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2028) 7.4 Europe Retinitis Pigmentosa Treatment & Management Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) 8.2 Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2028) 8.3 Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2028) 8.4 Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) 9.2 Latin America Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2028) 9.3 Latin America Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2028) 9.4 Latin America Retinitis Pigmentosa Treatment & Management Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) 10.2 Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2028) 10.3 Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2028) 10.4 Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 U.A.E 11 Company Profiles 11.1 ReNeuron 11.1.1 ReNeuron Company Details 11.1.2 ReNeuron Business Overview 11.1.3 ReNeuron Retinitis Pigmentosa Treatment & Management Products and Services 11.1.4 ReNeuron Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) 11.1.5 ReNeuron Retinitis Pigmentosa Treatment & Management SWOT Analysis 11.1.6 ReNeuron Recent Developments 11.2 Amarantus BioScience 11.2.1 Amarantus BioScience Company Details 11.2.2 Amarantus BioScience Business Overview 11.2.3 Amarantus BioScience Retinitis Pigmentosa Treatment & Management Products and Services 11.2.4 Amarantus BioScience Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) 11.2.5 Amarantus BioScience Retinitis Pigmentosa Treatment & Management SWOT Analysis 11.2.6 Amarantus BioScience Recent Developments 11.3 Ocugen 11.3.1 Ocugen Company Details 11.3.2 Ocugen Business Overview 11.3.3 Ocugen Retinitis Pigmentosa Treatment & Management Products and Services 11.3.4 Ocugen Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) 11.3.5 Ocugen Retinitis Pigmentosa Treatment & Management SWOT Analysis 11.3.6 Ocugen Recent Developments 11.4 ReGenX Biosciences 11.4.1 ReGenX Biosciences Company Details 11.4.2 ReGenX Biosciences Business Overview 11.4.3 ReGenX Biosciences Retinitis Pigmentosa Treatment & Management Products and Services 11.4.4 ReGenX Biosciences Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) 11.4.5 ReGenX Biosciences Retinitis Pigmentosa Treatment & Management SWOT Analysis 11.4.6 ReGenX Biosciences Recent Developments 11.5 Sucampo Pharmaceuticals 11.5.1 Sucampo Pharmaceuticals Company Details 11.5.2 Sucampo Pharmaceuticals Business Overview 11.5.3 Sucampo Pharmaceuticals Retinitis Pigmentosa Treatment & Management Products and Services 11.5.4 Sucampo Pharmaceuticals Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) 11.5.5 Sucampo Pharmaceuticals Retinitis Pigmentosa Treatment & Management SWOT Analysis 11.5.6 Sucampo Pharmaceuticals Recent Developments 11.6 Orphagen Pharmaceuticals 11.6.1 Orphagen Pharmaceuticals Company Details 11.6.2 Orphagen Pharmaceuticals Business Overview 11.6.3 Orphagen Pharmaceuticals Retinitis Pigmentosa Treatment & Management Products and Services 11.6.4 Orphagen Pharmaceuticals Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) 11.6.5 Orphagen Pharmaceuticals Retinitis Pigmentosa Treatment & Management SWOT Analysis 11.6.6 Orphagen Pharmaceuticals Recent Developments 11.7 Okuvision 11.7.1 Okuvision Company Details 11.7.2 Okuvision Business Overview 11.7.3 Okuvision Retinitis Pigmentosa Treatment & Management Products and Services 11.7.4 Okuvision Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) 11.7.5 Okuvision Retinitis Pigmentosa Treatment & Management SWOT Analysis 11.7.6 Okuvision Recent Developments 11.8 Second Sight Medical 11.8.1 Second Sight Medical Company Details 11.8.2 Second Sight Medical Business Overview 11.8.3 Second Sight Medical Retinitis Pigmentosa Treatment & Management Products and Services 11.8.4 Second Sight Medical Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) 11.8.5 Second Sight Medical Retinitis Pigmentosa Treatment & Management SWOT Analysis 11.8.6 Second Sight Medical Recent Developments 12 Retinitis Pigmentosa Treatment & Management Market Dynamics 12.1 Retinitis Pigmentosa Treatment & Management Market Trends 12.2 Retinitis Pigmentosa Treatment & Management Market Drivers 12.3 Retinitis Pigmentosa Treatment & Management Market Challenges 12.4 Retinitis Pigmentosa Treatment & Management Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Retinitis Pigmentosa Treatment & Management Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Vitamin A Table 3. Key Players of Docosahexaenoic Acid Table 4. Key Players of Calcium Channel Blockers Table 5. Key Players of Gene Therapy Table 6. Key Players of Retinal Eye Prosthetics Table 7. Global Retinitis Pigmentosa Treatment & Management Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 8. Global Retinitis Pigmentosa Treatment & Management Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 9. Global Retinitis Pigmentosa Treatment & Management Revenue by Region (2017-2022) & (US$ Million) Table 10. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Region (2017-2022) Table 11. Global Retinitis Pigmentosa Treatment & Management Revenue by Players (2017-2022) & (US$ Million) Table 12. Global Retinitis Pigmentosa Treatment & Management Market Share by Players (2017-2022) Table 13. Global Top Retinitis Pigmentosa Treatment & Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa Treatment & Management as of 2021) Table 14. Ranking of Global Top Retinitis Pigmentosa Treatment & Management Companies by Revenue (US$ Million) in 2021 Table 15. Global 5 Largest Players Market Share by Retinitis Pigmentosa Treatment & Management Revenue (CR5 and HHI) & (2017-2022) Table 16. Key Players Headquarters and Area Served Table 17. Key Players Retinitis Pigmentosa Treatment & Management Product Solution and Service Table 18. Date of Key Manufacturers Enter into Retinitis Pigmentosa Treatment & Management Market Table 19. Mergers & Acquisitions, Expansion Plans Table 20. Global Retinitis Pigmentosa Treatment & Management Market Size by Type (2017-2022) & (US$ Million) Table 21. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2017-2022) Table 22. Global Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 23. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2023-2028) Table 24. Global Retinitis Pigmentosa Treatment & Management Market Size by Application (2017-2022) & (US$ Million) Table 25. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2017-2022) Table 26. Global Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 27. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2023-2028) Table 28. North America Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) & (US$ Million) Table 29. North America Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2022) & (US$ Million) Table 30. North America Retinitis Pigmentosa Treatment & Management Revenue by Type (2023-2028) & (US$ Million) Table 31. North America Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2022) & (US$ Million) Table 32. North America Retinitis Pigmentosa Treatment & Management Revenue by Application (2023-2028) & (US$ Million) Table 33. North America Retinitis Pigmentosa Treatment & Management Revenue by Country (2017-2022) & (US$ Million) Table 34. North America Retinitis Pigmentosa Treatment & Management Revenue by Country (2023-2028) & (US$ Million) Table 35. Europe Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) & (US$ Million) Table 36. Europe Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2022) & (US$ Million) Table 37. Europe Retinitis Pigmentosa Treatment & Management Revenue by Type (2023-2028) & (US$ Million) Table 38. Europe Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2022) & (US$ Million) Table 39. Europe Retinitis Pigmentosa Treatment & Management Revenue by Application (2023-2028) & (US$ Million) Table 40. Europe Retinitis Pigmentosa Treatment & Management Revenue by Country (2017-2022) & (US$ Million) Table 41. Europe Retinitis Pigmentosa Treatment & Management Revenue by Country (2023-2028) & (US$ Million) Table 42. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) & (US$ Million) Table 43. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue by Region (2023-2028) & (US$ Million) Table 49. Latin America Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) & (US$ Million) Table 50. Latin America Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2022) & (US$ Million) Table 51. Latin America Retinitis Pigmentosa Treatment & Management Revenue by Type (2023-2028) & (US$ Million) Table 52. Latin America Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2022) & (US$ Million) Table 53. Latin America Retinitis Pigmentosa Treatment & Management Revenue by Application (2023-2028) & (US$ Million) Table 54. Latin America Retinitis Pigmentosa Treatment & Management Revenue by Country (2017-2022) & (US$ Million) Table 55. Latin America Retinitis Pigmentosa Treatment & Management Revenue by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Company (2020-2022) & (US$ Million) Table 57. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue by Country (2023-2028) & (US$ Million) Table 63. ReNeuron Company Details Table 64. ReNeuron Business Overview Table 65. ReNeuron Retinitis Pigmentosa Treatment & Management Product and Services Table 66. ReNeuron Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) & (US$ Million) Table 67. ReNeuron Retinitis Pigmentosa Treatment & Management SWOT Analysis Table 68. ReNeuron Recent Developments Table 69. Amarantus BioScience Company Details Table 70. Amarantus BioScience Business Overview Table 71. Amarantus BioScience Retinitis Pigmentosa Treatment & Management Product and Services Table 72. Amarantus BioScience Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) & (US$ Million) Table 73. Amarantus BioScience Retinitis Pigmentosa Treatment & Management SWOT Analysis Table 74. Amarantus BioScience Recent Developments Table 75. Ocugen Company Details Table 76. Ocugen Business Overview Table 77. Ocugen Retinitis Pigmentosa Treatment & Management Product and Services Table 78. Ocugen Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) & (US$ Million) Table 79. Ocugen Retinitis Pigmentosa Treatment & Management SWOT Analysis Table 80. Ocugen Recent Developments Table 81. ReGenX Biosciences Company Details Table 82. ReGenX Biosciences Business Overview Table 83. ReGenX Biosciences Retinitis Pigmentosa Treatment & Management Product and Services Table 84. ReGenX Biosciences Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) & (US$ Million) Table 85. ReGenX Biosciences Retinitis Pigmentosa Treatment & Management SWOT Analysis Table 86. ReGenX Biosciences Recent Developments Table 87. Sucampo Pharmaceuticals Company Details Table 88. Sucampo Pharmaceuticals Business Overview Table 89. Sucampo Pharmaceuticals Retinitis Pigmentosa Treatment & Management Product and Services Table 90. Sucampo Pharmaceuticals Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) & (US$ Million) Table 91. Sucampo Pharmaceuticals Retinitis Pigmentosa Treatment & Management SWOT Analysis Table 92. Sucampo Pharmaceuticals Recent Developments Table 93. Orphagen Pharmaceuticals Company Details Table 94. Orphagen Pharmaceuticals Business Overview Table 95. Orphagen Pharmaceuticals Retinitis Pigmentosa Treatment & Management Product and Services Table 96. Orphagen Pharmaceuticals Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) & (US$ Million) Table 97. Orphagen Pharmaceuticals Retinitis Pigmentosa Treatment & Management SWOT Analysis Table 98. Orphagen Pharmaceuticals Recent Developments Table 99. Okuvision Company Details Table 100. Okuvision Business Overview Table 101. Okuvision Retinitis Pigmentosa Treatment & Management Product and Services Table 102. Okuvision Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) & (US$ Million) Table 103. Okuvision Retinitis Pigmentosa Treatment & Management SWOT Analysis Table 104. Okuvision Recent Developments Table 105. Second Sight Medical Company Details Table 106. Second Sight Medical Business Overview Table 107. Second Sight Medical Retinitis Pigmentosa Treatment & Management Product and Services Table 108. Second Sight Medical Retinitis Pigmentosa Treatment & Management Revenue in Retinitis Pigmentosa Treatment & Management Business (2017-2022) & (US$ Million) Table 109. Second Sight Medical Retinitis Pigmentosa Treatment & Management SWOT Analysis Table 110. Second Sight Medical Recent Developments Table 111. Retinitis Pigmentosa Treatment & Management Market Trends Table 112. Retinitis Pigmentosa Treatment & Management Market Drivers Table 113. Retinitis Pigmentosa Treatment & Management Market Challenges Table 114. Retinitis Pigmentosa Treatment & Management Market Restraints Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Retinitis Pigmentosa Treatment & Management Sales Market Share by Type: 2021 VS 2028 Figure 2. Vitamin A Features Figure 3. Docosahexaenoic Acid Features Figure 4. Calcium Channel Blockers Features Figure 5. Gene Therapy Features Figure 6. Retinal Eye Prosthetics Features Figure 7. Global Retinitis Pigmentosa Treatment & Management Sales Market Share by Application: 2021 VS 2028 Figure 8. Hospitals Case Studies Figure 9. Ambulatory Surgical Centers Case Studies Figure 10. Others Case Studies Figure 11. Retinitis Pigmentosa Treatment & Management Report Years Considered Figure 12. Global Retinitis Pigmentosa Treatment & Management Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Retinitis Pigmentosa Treatment & Management Market Size 2017-2028 (US$ Million) Figure 14. Global Retinitis Pigmentosa Treatment & Management Market Size Market Share by Region: 2021 VS 2028 Figure 15. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Region in 2017 VS 2022 Figure 16. Global Top 10 Retinitis Pigmentosa Treatment & Management Countries Ranking by Market Size (US$ Million) in 2021 Figure 17. Global Retinitis Pigmentosa Treatment & Management Market Share by Players in 2021 Figure 18. Global Top Retinitis Pigmentosa Treatment & Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa Treatment & Management as of 2021) Figure 19. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa Treatment & Management Revenue in 2021 Figure 20. North America Retinitis Pigmentosa Treatment & Management Revenue Market Share by Company in 2021 Figure 21. North America Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2017-2028) Figure 22. North America Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2017-2028) Figure 23. North America Retinitis Pigmentosa Treatment & Management Revenue Share by Country (2017-2028) Figure 24. U.S. Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 25. Canada Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 26. Europe Retinitis Pigmentosa Treatment & Management Revenue Market Share by Company in 2021 Figure 27. Europe Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2017-2028) Figure 28. Europe Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2017-2028) Figure 29. Europe Retinitis Pigmentosa Treatment & Management Revenue Share by Country (2017-2028) Figure 30. Germany Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 31. France Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 32. U.K. Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 33. Italy Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 34. Russia Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 35. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue Market Share by Company in 2021 Figure 36. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2017-2028) Figure 37. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2017-2028) Figure 38. Asia Pacific Retinitis Pigmentosa Treatment & Management Revenue Share by Region (2017-2028) Figure 39. China Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 40. Japan Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 41. South Korea Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 42. India Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 43. Australia Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 44. Taiwan Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 45. Indonesia Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 46. Thailand Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 47. Malaysia Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 48. Philippines Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 49. Vietnam Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 50. Latin America Retinitis Pigmentosa Treatment & Management Revenue Market Share by Company in 2021 Figure 51. Latin America Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2017-2028) Figure 52. Latin America Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2017-2028) Figure 53. Latin America Retinitis Pigmentosa Treatment & Management Revenue Share by Country (2017-2028) Figure 54. Mexico Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 55. Brazil Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 56. Argentina Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 57. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue Market Share by Company in 2021 Figure 58. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2017-2028) Figure 59. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2017-2028) Figure 60. Middle East and Africa Retinitis Pigmentosa Treatment & Management Revenue Share by Country (2017-2028) Figure 61. Turkey Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 62. Saudi Arabia Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 63. U.A.E Retinitis Pigmentosa Treatment & Management Revenue (2017-2028) & (US$ Million) Figure 64. ReNeuron Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2017-2022) Figure 65. Amarantus BioScience Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2017-2022) Figure 66. Ocugen Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2017-2022) Figure 67. ReGenX Biosciences Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2017-2022) Figure 68. Sucampo Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2017-2022) Figure 69. Orphagen Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2017-2022) Figure 70. Okuvision Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2017-2022) Figure 71. Second Sight Medical Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

ReNeuron Amarantus BioScience Ocugen ReGenX Biosciences Sucampo Pharmaceuticals Orphagen Pharmaceuticals Okuvision Second Sight Medical